1. Home
  2. DRUG vs CNNE Comparison

DRUG vs CNNE Comparison

Compare DRUG & CNNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$76.77

Market Cap

707.1M

Sector

Health Care

ML Signal

HOLD

CNNE

Cannae Holdings Inc.

HOLD

Current Price

$14.68

Market Cap

609.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRUG
CNNE
Founded
2019
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
707.1M
609.0M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
DRUG
CNNE
Price
$76.77
$14.68
Analyst Decision
Strong Buy
Buy
Analyst Count
6
4
Target Price
$129.25
$20.25
AVG Volume (30 Days)
323.2K
445.9K
Earning Date
05-15-2026
05-11-2026
Dividend Yield
N/A
4.47%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$499,700,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.37
52 Week Low
$24.18
$10.46
52 Week High
$123.75
$21.96

Technical Indicators

Market Signals
Indicator
DRUG
CNNE
Relative Strength Index (RSI) 59.97 57.87
Support Level $70.35 $13.83
Resistance Level $91.80 $14.99
Average True Range (ATR) 5.22 0.45
MACD 1.95 0.01
Stochastic Oscillator 89.57 87.01

Price Performance

Historical Comparison
DRUG
CNNE

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

About CNNE Cannae Holdings Inc.

Cannae Holdings Inc is an investment holding company that acquires and actively manages equity interests in operating businesses across various industries. The Company focuses on long-term ownership and seeks to create value by supporting the growth and operations of its portfolio companies through management expertise and strategic oversight. The Company operates through four reportable segments: Restaurant Group, which includes the operations of O'Charleys and 99 Restaurants; Alight, which represents its ownership interest in a technology-enabled human capital and employee benefits solutions provider; Black Knight Football Club (BKFC), which holds interests in professional football clubs; and JANA, which represents its investment in an investment management firm.

Share on Social Networks: